Vivos Therapeutics's market cap is currently ―. The company's EPS TTM is $-10.407; its P/E ratio is -0.26; Vivos Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 3.30M	$ 3.40M	$ 2.08M	$ 4.13M	$ 4.25M
Gross Profit	$ 1.75M	$ 2.10M	$ 2.34M	$ 2.57M	$ 2.50M
EBIT	$ -2.09M	$ -5.61M	$ 15.86M	$ -5.99M	$ -5.41M
EBITDA	$ -1.94M	$ -5.46M	$ 15.69M	$ -5.82M	$ -5.23M
Net Income Common Stockholders	$ -2.09M	$ -5.53M	$ 9.48M	$ -5.90M	$ -5.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.00M	$ 3.90M	$ 7.00M	$ 3.50M	$ 6.72M
Total Assets	$ 10.32M	$ 13.71M	$ 17.10M	$ 13.72M	$ 18.40M
Total Debt	$ 2.10M	$ 2.21M	$ 2.31M	$ 2.41M	$ 2.85M
Net Debt	$ 1.10M	$ -1.69M	$ -4.68M	$ -1.09M	$ -3.87M
Total Liabilities	$ 10.30M	$ 11.64M	$ 10.10M	$ 8.90M	$ 8.54M
Stockholders Equity	$ 46.00K	$ 2.10M	$ 6.99M	$ 4.80M	$ 9.86M
Cash Flow	-
Free Cash Flow	$ -2.95M	$ -3.13M	$ -3.80M	$ -3.20M	$ -5.94M
Operating Cash Flow	$ -2.80M	$ -2.88M	$ -3.51M	$ -3.00M	$ -5.84M
Investing Cash Flow	$ -154.00K	$ -245.00K	$ -289.00K	$ -200.00K	$ -100.00K
Financing Cash Flow	-	-	$ 7.36M	-	$ 0.00

Currency in USD

Vivos Therapeutics Earnings and Revenue History

Income Statement >

Vivos Therapeutics Debt to Assets

Balance Sheet >

Vivos Therapeutics Cash Flow

Cash Flow >

Vivos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing